BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24447276)

  • 1. Peptides derived from phage display libraries as potential neutralizers of Shiga toxin-induced cytotoxicity in vitro and in vivo.
    Bernedo-Navarro RA; Miyachiro MM; da Silva MJ; Reis CF; Conceição RA; Gatti MS; Yano T
    J Appl Microbiol; 2014 May; 116(5):1322-33. PubMed ID: 24447276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions.
    Tsutsuki K; Watanabe-Takahashi M; Takenaka Y; Kita E; Nishikawa K
    Infect Immun; 2013 Jun; 81(6):2133-8. PubMed ID: 23545297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.
    Luz D; Chen G; Maranhão AQ; Rocha LB; Sidhu S; Piazza RM
    PLoS One; 2015; 10(3):e0120481. PubMed ID: 25790467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological investigation of Shiga toxin-producing Escherichia coli isolates originated from healthy sheep in one farm of Jiangsu Province and their pathogenicity].
    Gu C; Xue T; Xu T; Gao S; Jiao X; Liu X
    Wei Sheng Wu Xue Bao; 2011 May; 51(5):676-83. PubMed ID: 21800631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalein Inhibits Stx1 and 2 of EHE: Effects of Baicalein on the Cytotoxicity, Production, and Secretion of Shiga Toxins of Enterohaemorrhagic Escherichia coli.
    Vinh PT; Shinohara Y; Yamada A; Duc HM; Nakayama M; Ozawa T; Sato J; Masuda Y; Honjoh KI; Miyamoto T
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31470657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of rabbit polyclonal sera against Shiga toxins Stx1 and Stx2 for detection of Shiga toxin-producing Escherichia coli.
    Mendes-Ledesma MR; Rocha LB; Bueris V; Krause G; Beutin L; Franzolin MR; Trabulsi LR; Elias WP; Piazza RM
    Microbiol Immunol; 2008 Oct; 52(10):484-91. PubMed ID: 18822082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex real-time PCR assay for detection of Escherichia coli O157:H7 and screening for non-O157 Shiga toxin-producing E. coli.
    Li B; Liu H; Wang W
    BMC Microbiol; 2017 Nov; 17(1):215. PubMed ID: 29121863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli.
    Nishikawa K
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):239-47. PubMed ID: 21644029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shiga Toxin (Stx)-Binding Glycosphingolipids of Primary Human Renal Cortical Epithelial Cells (pHRCEpiCs) and Stx-Mediated Cytotoxicity.
    Detzner J; Krojnewski E; Pohlentz G; Steil D; Humpf HU; Mellmann A; Karch H; Müthing J
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33673393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of Shiga toxin-producing Escherichia coli (STEC) isolated from seafood and beef.
    Kumar HS; Karunasagar I; Karunasagar I; Teizou T; Shima K; Yamasaki S
    FEMS Microbiol Lett; 2004 Apr; 233(1):173-8. PubMed ID: 15043885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Escherichia coli Isolates from humans, food, and farm and companion animals for presence of Shiga toxin-producing E. coli virulence markers.
    Murinda SE; Nguyen LT; Landers TL; Draughon FA; Mathew AG; Hogan JS; Smith KL; Hancock DD; Oliver SP
    Foodborne Pathog Dis; 2004; 1(3):178-84. PubMed ID: 15992278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnamon Oil Inhibits Shiga Toxin Type 2 Phage Induction and Shiga Toxin Type 2 Production in Escherichia coli O157:H7.
    Sheng L; Rasco B; Zhu MJ
    Appl Environ Microbiol; 2016 Nov; 82(22):6531-6540. PubMed ID: 27590808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.
    Luz D; Gómez FD; Ferreira RL; Melo BS; Guth BEC; Quintilio W; Moro AM; Presta A; Sacerdoti F; Ibarra C; Chen G; Sidhu SS; Amaral MM; Piazza RMF
    Toxins (Basel); 2021 Nov; 13(11):. PubMed ID: 34822608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli serogroup O107/O117 lipopolysaccharide binds and neutralizes Shiga toxin 2.
    Gamage SD; McGannon CM; Weiss AA
    J Bacteriol; 2004 Aug; 186(16):5506-12. PubMed ID: 15292153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the Ridascreen Verotoxin enzyme immunoassay for detection of Shiga-toxin producing strains of Escherichia coli (STEC) from food and other sources.
    Beutin L; Steinrück H; Krause G; Steege K; Haby S; Hultsch G; Appel B
    J Appl Microbiol; 2007 Mar; 102(3):630-9. PubMed ID: 17309611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
    Pellino CA; Karve SS; Pradhan S; Weiss AA
    J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human intestinal tissue and cultured colonic cells contain globotriaosylceramide synthase mRNA and the alternate Shiga toxin receptor globotetraosylceramide.
    Zumbrun SD; Hanson L; Sinclair JF; Freedy J; Melton-Celsa AR; Rodriguez-Canales J; Hanson JC; O'Brien AD
    Infect Immun; 2010 Nov; 78(11):4488-99. PubMed ID: 20732996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms.
    Angel Villegas N; Baronetti J; Albesa I; Etcheverría A; Becerra MC; Padola NL; Paraje MG
    Toxicol In Vitro; 2015 Oct; 29(7):1692-700. PubMed ID: 26130220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins.
    Neri P; Nagano SI; Yokoyama S; Dohi H; Kobayashi K; Miura T; Inazu T; Sugiyama T; Nishida Y; Mori H
    Microbiol Immunol; 2007; 51(6):581-92. PubMed ID: 17579269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.